The National Breast Cancer Foundation (NBCF), supported by funds raised entirely by the Australian public, aims to eliminate breast cancer related deaths by 2030. The 2019 Investigator Initiated Research Scheme will aid in the prevention and cure of breast cancer by funding research projects in the following priority areas:
- New/optimized treatments for triple negative breast cancer, comprising new target discovery, new delivery methods, new drugs, new therapeutic regimes etc.
- New/optimized treatments for metastatic/locally advanced breast cancer comprising new target discovery, new delivery methods, new drugs, new therapeutic regimes etc.
- Health services delivery, comprising big data linkage, epidemiological research to address disparities and variances in outcomes, translation of evidence into policy and practice, quality of healthcare etc.
This scheme encourages proposals involving highly innovative and original ideas, and projects that will yield preliminary data for use in future funding applications.
Scientists from all stages of their career are eligible to apply, with a particular focus on support for mid-career researchers.
Funding & Duration
- Principal Investigators (PIs) cannot have in excess of $2M in NBCF funding in any one year.
- Funding is available for a period of 1 – 5 years.
- View the Application Guidelines (PDF) for eligibility criteria.
Submission Requirements & Due Date
- Applications must be submitted for internal review by 27 April 2018
- Please complete your RFR through ResearchMaster. When prompted to Select Fund Scheme use Fund Scheme code FND000309
- Submit an Application to Research Services for Review